Real-world treatment patterns of OTX-101 ophthalmic solution, cyclosporine ophthalmic emulsion, and lifitegrast ophthalmic solution in patients with dry eye disease: a retrospective analysis

BACKGROUND: Dry eye disease (DED) is a disorder characterized by loss of tear film homeostasis that causes ocular surface inflammation and damage. The incidence of DED increases with age. Cyclosporine ophthalmic solution 0.09% (CEQUA(®); OTX-101), cyclosporine ophthalmic emulsion 0.05% (Restasis(®);...

Descripción completa

Detalles Bibliográficos
Autores principales: Karpecki, Paul, Barghout, Victoria, Schenkel, Brad, Huynh, Lynn, Khanal, Anamika, Mitchell, Brittany, Yenikomshian, Mihran, Zanardo, Enrico, Matossian, Cynthia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621228/
https://www.ncbi.nlm.nih.gov/pubmed/37919692
http://dx.doi.org/10.1186/s12886-023-03174-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621228/
https://www.ncbi.nlm.nih.gov/pubmed/37919692
http://dx.doi.org/10.1186/s12886-023-03174-y

Ejemplares similares